Cited skincare — every flag names its source, no upsell.
Re

Retinyl palmitate

Retinyl PalmitateActive

Ester form of vitamin A. The mildest of the common retinoids, with the thinnest evidence for visible benefit.

What it does

Retinyl palmitate must be converted twice (to retinol, then to retinoic acid) before becoming active. Common in moisturizers and SPF products as a marketing-friendly retinoid that rarely irritates. Evidence for visible benefit is limited compared to retinol or tretinoin.

The evidence, graded

strongNo topical retinoid is recommended in pregnancy. The class covers tretinoin, adapalene, tazarotene, trifarotene, retinol, retinaldehyde, retinyl palmitate and hydroxypinacolone retinoate. Direct human data exist mainly for tretinoin and adapalene. The caution extends to the rest as a class-effect. Data on accidental exposure reassure, but are not strong enough to recommend any retinoid here. Oral isotretinoin is a separate case, with an absolute contraindication.Kaplan 2015 · British Journal of Dermatology
expert consensusFor cosmetic anti-aging purposes, retinoids are not recommended under 18. Teen skin is already producing high collagen and cell turnover, and retinoid use in young people is reserved for treating conditions like acne — not for prevention of aging.Motamedi 2021 · Journal of Cutaneous Medicine and Surgery

Graded per the methodology: strong · moderate · emerging · expert consensus. A weak source on a strong claim gets the weaker label.

Also known as

vitamin a palmitate

Pairs worth knowing

Browse all 668 ingredients — grouped by what they do, each with whatever evidence we can cite.

This page is public so a shared ingredient card always has its sources behind it — and so you can check them without an account.
Want more like this?
Every evidence-based flag cites its source, Drop tells you when your routine is complete, and it helps you simplify — instead of selling you more. The app launches on iOS and Android in October 2026. Rate my routine works today at /rate — no sign-in.